LGND: Ligand Pharmaceuticals Incorporated
今日LGND汇率已更改-2.21%。当日,交易品种以低点305.34和高点315.27进行交易。
关注Ligand Pharmaceuticals Incorporated动态。实时报价将帮助您快速应对市场变化。通过在不同的时间周期之间切换,您可以按分钟、小时、天、周和月监控汇率趋势和动态。使用这些信息来预测市场变化并做出明智的交易决策。
- M5
- M15
- M30
- H1
- H4
- D1
- W1
- MN
LGND新闻
- Stock Market Today: Nasdaq Hit As Inflation Runs Hot; Dell Slumps, But These Biotech Names Gain (Live Coverage)
- Here's How Much $1000 Invested In Ligand Pharmaceuticals 15 Years Ago Would Be Worth Today
- Full Transcript: Ligand Pharmaceuticals Q2 2026 Earnings Call
- 巴克莱启动利健制药的覆盖,给予超重评级,宣布目标股价为345美元
- Barclays Initiates Coverage On Ligand Pharmaceuticals with Overweight Rating, Announces Price Target of $345
- HC Wainwright & Co.重申对利嘉制药的买入评级,维持358美元的目标股价
- HC Wainwright & Co. Reiterates Buy on Ligand Pharmaceuticals, Maintains $358 Price Target
- 配体宣布向CAR-T疗法开发商AvenCell融资最高4700万美元,其中包括最高4100万美元用于管线特许权
- Citigroup Maintains Buy on Ligand Pharmaceuticals, Raises Price Target to $397
- 花旗集团维持对利嘉制药的买入评级,并将目标股价上调至397美元
- Sydnexis Signs $23M Agreement With Ligand Pharmaceuticals To Sell Its Royalty Rights Associated With Net Sales Of Ryjunea In EMEA
- Sydnexis与Ligand Pharmaceuticals签署价值2300万美元的协议,出售其在EMEA地区与Ryjunea销售相关的版税权利
- Ligand Pharmaceuticals Announces Acquisition Of EMEA Royalty On Santen's Pediatric Myopia Drug Ryjunea From Sydnexis For $23M Upfront
- 利凡德制药宣布以2300万美元首付收购Sydnexis在三兆妙的儿童近视药物Ryjunea的EMEA版税
- Here’s How Much You Would Have Made Owning Ligand Pharmaceuticals Stock In The Last 5 Years
- 在过去5年持有利健制药股票将获得的收益是多少
- Ligand Pharmaceuticals: The Multiple Is The Whole Be; Hold (NASDAQ:LGND)
- Bank Of New York Mellon Hits Record High, Among Group Of 16 New To Best Stock Lists
- Oil Industry Giant Valero Pops To Record High, Leads Group Of 14 Onto Best Stock Lists
- Phillips 66 Hits Record High, Leads Lucky 13 Stocks Onto Best Stock Lists
- Breakout Watch: Savvy Investors Bet Millions On Royalty-Fueled Pharma Stock
- Palantir Popped 39% This Week, Leads 27 To Best Stock Lists
- Dow Jones Futures: Cloudflare Leads 5 Software Earnings Winners Late; Jobs Report On Tap
- Why This Biotech Dealmaker — Tied To Merck, Travere — Charged Higher
常见问题解答
LGND股票今天的价格是多少?
Ligand Pharmaceuticals Incorporated股票今天的定价为307.82。它在305.34 - 315.27范围内交易,昨天的收盘价为314.78,交易量达到568。LGND的实时价格图表显示了这些更新。
Ligand Pharmaceuticals Incorporated股票是否支付股息?
Ligand Pharmaceuticals Incorporated目前的价值为307.82。股息政策取决于公司,而投资者也会关注59.52%和USD。实时查看图表以跟踪LGND走势。
如何购买LGND股票?
您可以以307.82的当前价格购买Ligand Pharmaceuticals Incorporated股票。订单通常设置在307.82或308.12附近,而568和-1.65%显示市场活动。立即关注LGND的实时图表更新。
如何投资LGND股票?
投资Ligand Pharmaceuticals Incorporated需要考虑年度范围175.89 - 326.63和当前价格307.82。许多人在以307.82或308.12下订单之前,会比较-0.65%和。实时查看LGND价格图表,了解每日变化。
Ligand Pharmaceuticals Incorporated股票的最高价格是多少?
在过去一年中,Ligand Pharmaceuticals Incorporated的最高价格是326.63。在175.89 - 326.63内,该股波动显著,与相比有助于发现阻力位。使用实时图表跟踪Ligand Pharmaceuticals Incorporated的绩效。
Ligand Pharmaceuticals Incorporated股票的最低价格是多少?
Ligand Pharmaceuticals Incorporated(LGND)的最低价格为175.89。将其与当前的307.82和175.89 - 326.63进行比较,可以发现潜在的长期切入点。观看LGND在图表上的实时走势以获取更多详细信息。
LGND股票是什么时候拆分的?
Ligand Pharmaceuticals Incorporated历史上曾经历过股票拆分。这些变化在公司行动后的、314.78和59.52%中可见。
- 前一天收盘价
- 314.78
- 开盘价
- 313.00
- 卖价
- 307.82
- 买价
- 308.12
- 最低价
- 305.34
- 最高价
- 315.27
- 交易量
- 568
- 日变化
- -2.21%
- 月变化
- -0.65%
- 6个月变化
- 33.91%
- 年变化
- 59.52%
- 实际值
- 预测值
- 46.3
- 前值
- 46.3
- 实际值
- 预测值
- 47.3
- 前值
- 47.3
- 实际值
- 预测值
- 4.7%
- 前值
- 4.7%
- 实际值
- 预测值
- 3.5%
- 前值
- 3.5%
- 实际值
- 预测值
- 前值
- 实际值
- 预测值
- 前值
- 实际值
- 预测值
- 前值
- 207.9 K
- 实际值
- 预测值
- 前值
- 100.3 K
- 实际值
- 预测值
- 前值
- -141.0 K
- 实际值
- 预测值
- 前值
- 48.5 K